
Coral Care's $13 Million Funding Boost to Expand In-Home Pediatric Therapy Services
In a significant advancement for pediatric healthcare delivery, Coral Care secured $13 million in Series A funding led by Haymaker Ventures. This investment aims to scale Coral Care's innovative in-home therapy services for children, improving access and outcomes for young patients suffering from developmental and physical challenges. The funding round attracted multiple strategic investors, underlining confidence in Coral Care's mission to transform pediatric care.
Coral Care has announced a successful Series A funding round, raising $13 million to support the scaling of its in-home pediatric therapy platform. This financial injection is critical for Coral Care as it seeks to broaden access to specialized therapeutic interventions within the home environment, a model increasingly recognized for its benefits in patient comfort, family involvement, and continuity of care.
Leading this investment round was Haymaker Ventures, a venture capital firm known for backing healthcare innovations that deliver impactful patient outcomes. Additional participation came from an array of experienced healthcare-focused investment entities, including FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures, and Charge Ventures. The diverse and reputable investor base reflects strong market confidence in Coral Care’s business strategy and the therapeutic value it provides.
The challenge Coral Care addresses is clear: traditional pediatric therapy often requires frequent travel to specialized clinics, which can be a substantial barrier for many families. In contrast, Coral Care's model delivers physical, occupational, and speech therapy directly to children in their homes, allowing for more personalized, flexible scheduling and environments tailored to each child’s needs.
Given the rising prevalence of developmental and physical challenges in pediatric populations and the heightened demand for accessible therapies, Coral Care’s approach represents an important innovation in healthcare delivery. By enabling certified therapists to conduct in-home sessions, Coral Care not only improves therapy adherence but also allows therapists to observe and integrate the child’s natural context into treatment plans.
This funding round will notably support the expansion of Coral Care's therapist network, technology enhancements for remote and in-person care management, and customer acquisition to reach underserved regions. Additionally, the capital will be used to strengthen operational infrastructure and scale care coordination capabilities.
The involvement of multiple investors specializing in healthcare innovation aligns Coral Care with a network that can provide strategic guidance, industry connections, and potential partnership opportunities. This collaborative ecosystem is expected to facilitate Coral Care's growth trajectory and further solidify its role as a leading provider in pediatric therapy services.
In summary, Coral Care’s $13 million Series A funding demonstrates a significant vote of confidence in in-home pediatric care solutions. As health systems and families increasingly seek convenient, effective therapeutic options, Coral Care's scalable platform positions it well to impact outcomes positively for children requiring developmental support. Continued investments in this space reflect a broader shift towards patient-centric, home-based healthcare interventions, driven by technological enablement and evolving care paradigms.
Sources: Coral Care Raises $13M to Scale In-Home Pediatric Therapy
Join the BioIntel newsletter
Get curated biotech intelligence across AI, industry, innovation, investment, medtech, and policy—delivered to your inbox.